Gainers
- Kala Pharmaceuticals KALA stock moved upwards by 68.1% to $6.59 during Tuesday's after-market session. Kala Pharmaceuticals's trading volume hit 860.6K shares by close, accounting for 468.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $10.0 million.
- SINTX Technologies SINT stock increased by 13.82% to $8.77. The company's market cap stands at $455.4 million.
- Benitec Biopharma BNTC stock rose 11.83% to $0.18. The market value of their outstanding shares is at $5.0 million.
- Vapotherm VAPO stock moved upwards by 10.19% to $2.98. The company's market cap stands at $79.4 million.
- LogicMark LGMK stock moved upwards by 9.28% to $0.44. The market value of their outstanding shares is at $4.2 million.
- Ikena Oncology IKNA stock increased by 7.8% to $2.9. The company's market cap stands at $105.1 million.
Losers
- Quotient QTNT stock decreased by 17.6% to $0.3 during Tuesday's after-market session. At the close, Quotient's trading volume reached 246.4K shares. This is 95.4% of its average volume over the last 100 days. The company's market cap stands at $1.0 million.
- Venus Concept VERO shares fell 7.79% to $0.26. This security traded at a volume of 64.1K shares come close, making up 3.4% of its average volume over the last 100 days. The company's market cap stands at $18.2 million.
- Mereo BioPharma Group MREO stock decreased by 7.55% to $0.51. The market value of their outstanding shares is at $63.1 million.
- ATI Physical Therapy ATIP shares fell 7.1% to $0.28. At the close, ATI Physical Therapy's trading volume reached 62.7K shares. This is 10.2% of its average volume over the last 100 days. The company's market cap stands at $57.7 million.
- Bone Biologics BBLG stock declined by 6.35% to $0.19. The market value of their outstanding shares is at $2.9 million.
- Healthcare Triangle HCTI shares declined by 6.01% to $0.18. The market value of their outstanding shares is at $7.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in